Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [15688]

HPV cancer vaccine slows tumour growth, extends survival in preclinical model

HPV cancer vaccine slows tumour growth, extends survival in preclinical model

Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer

Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer

Call for action on understudied lung cancer in never-smokers

Call for action on understudied lung cancer in never-smokers

Virus-based therapy boosts anti-cancer immune responses to brain cancer

Virus-based therapy boosts anti-cancer immune responses to brain cancer

FDA approves pembrolizumab with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

FDA approves pembrolizumab with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary...

Growth of spreading pancreatic cancer fueled by 'under-appreciated' epigenetic changes

Growth of spreading pancreatic cancer fueled by 'under-appreciated' epigenetic changes

New dual-action compound reduces pancreatic cancer cell growth

New dual-action compound reduces pancreatic cancer cell growth

Researchers discover genetic link to Barrett’s oesophagus offering new hope for oesophageal cancer patients

Researchers discover genetic link to Barrett’s oesophagus offering new hope for oesophageal cancer patients

Physical pressure on the brain triggers neurons’ self-destruction programming

Physical pressure on the brain triggers neurons’ self-destruction programming

First in-human study finds novel immune cell therapy is safe and effective in advanced lymphoma

First in-human study finds novel immune cell therapy is safe and effective in advanced lymphoma

More from ecancer